Last reviewed · How we verify

NCT06740331: COMET

Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

Recruiting now NA Last updated 13 March 2026
What this trial tests

NA trial testing Analysis of social cognition, memory functioning, and executive functioning processes in Bipolar Disorder and Major Depressive Disorder in 180 participants. Currently enrolling.

Timeline
7 January 2025
Primary endpoint
7 January 2028
7 February 2028

Quick facts

Lead sponsorCHU de Reims
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment180
Start date7 January 2025
Primary completion7 January 2028
Estimated completion7 February 2028
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

CHU de Reims — full company profile →

Who can join

Adults 18 to 65, any sex, with Bipolar Disorder and Major Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bipolar disorder (BD) are common psychiatric disorders often misdiagnosed, leading to delayed treatment. Even during stable phases, individuals with bipolar disorder experience residual cognitive impairments that affect their social functioning and quality of life. This study aims to explore social cognition deficits (e.g., emotional processing, theory of mind, attribution bias) and their relationship with executive functions (e.g., flexibility, inhibition, working memory) and memory in bipolar disorder and major depressive disorder, ultimately seeking to improve understanding of their functional outcomes. Social cognition and executive functions in BD are both state- and trait-related. One recent meta-analysis demonstrated impairment in social cognitive domains for manic, depressive, and euthymic bipolar disorders' patients but it remains unclear whether these social cognitive deficits in BD are due to executive functions and/or other confounding effects. Few studies have investigated the interdependency between these cognitive impairments in these two affective disorders while a better understanding of the link between executive functions and social cognition seems crucial in order to better characterize the nature of patients' deficits and thus their caring.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other CHU de Reims trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06740331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing